Close Menu

NEW YORK — Singaporean diagnostics firm One BioMed said today that it has closed a $5 million Series A round of financing.

The round was led by Biopath Ventures Arch and Venture Partners with participation from Singapore government-led investment group Seeds Capital. In conjunction with the round, BioPath's Joseph Jeong and Nick Roelofs will join One BioMed's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.